Synbiotics for MAFLD: gut health and liver fat study
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether taking a synbiotic (a mix of helpful bacteria and fiber) can improve insulin levels and reduce inflammation in people with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). It may help by changing the balance of bacteria in your gut.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 55 years old.
- You have been diagnosed with MAFLD (fatty liver) using a special scan called FibroScan, with a CAP score of 263 or higher.
- You are willing to take study supplements by mouth every day and keep a diary of when you take them.
- You have not taken antibiotics, probiotics, prebiotics, or synbiotics in the past month.
- You do not have hepatitis (B, C, or autoimmune), alcoholic liver disease, cirrhosis, or liver cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a probiotic supplement (a mix of helpful bacteria) can improve liver health in people with fatty liver disease linked to metabolic syndrome. It may help lower liver enzymes and reduce fat buildup in the liver.
This study looks at how a specific gut bacteria (Ruminococcus gnavus) and the chemicals it makes are linked to a type of fatty liver disease called MAFLD. By joining, you'll help researchers understand this connection, which may lead to better treatments in the future.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
This study tests whether a probiotic supplement can improve liver health in people with fatty liver disease. It aims to see if probiotics reduce liver fat or inflammation, which could help manage the condition.
This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.
This trial tests a digital health app designed to help people with metabolic-associated fatty liver disease (MAFLD). The app provides diet and exercise guidance to improve liver health.
Hear when a new Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.